Nonalcoholic Steatohepatitis (NASH) is Associated with Higher Coronary Heart Disease Risk

被引：0
|
作者：
Siddiqui, Mohammad [1 ]
Van Natta, Mark L. [2 ]
Belt, Patricia H. [2 ]
Clark, Jeanne M. [2 ]
Tonascia, James [2 ]
Chalasani, Naga P. [3 ]
Guy, Cynthia D. [4 ]
Hameed, Bilal [5 ]
Sanyal, Arun J. [1 ]
机构：
[1] Virginia Commonwealth Univ, Richmond, VA USA
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] Indiana Univ, Indianapolis, IN 46204 USA
[4] Duke Univ, Durham, NC USA
[5] UCSF, San Francisco, CA USA
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1073
引用
收藏
页码：541A / 541A
页数：1
相关论文
共 50 条
  • [1] Pioglitazone Discontinuation in Patients with Nonalcoholic Steatohepatitis (NASH) Is Associated with Disease Recurrence
    Bril, Fernando
    Lomonaco, Romina
    Kalavalapalli, Srilaxmi
    Lai, Jinping
    Cusi, Kenneth
    [J]. DIABETES, 2019, 68
  • [2] NASH - Nonalcoholic steatohepatitis
    Blechacz, B
    Stremmel, W
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2003, 41 (01): : 77 - 90
  • [3] Nonalcoholic steatohepatitis is associated with a higher risk of advanced colorectal neoplasm
    Cho, Yuri
    Lim, Soo-Kyung
    Joo, Sae Kyung
    Jeong, Dong-Hyong
    Kim, Jung Ho
    Bae, Jeong Mo
    Park, Jeong Hwan
    Chang, Mee Soo
    Lee, Dong Hyeon
    Jung, Yong Jin
    Kim, Byeong Gwan
    Kim, Donghee
    Lee, Kook Lae
    Kim, Won
    [J]. LIVER INTERNATIONAL, 2019, 39 (09) : 1722 - 1731
  • [4] Gallstones associated with nonalcoholic steatohepatitis (NASH) and metabolic syndrome
    Yener, Oktay
    Aksoy, Fikret
    Demir, Mustafa
    Ozcelik, Alp
    Erengul, Canan
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2010, 21 (04): : 411 - 415
  • [5] Microbiota and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH)
    Duarte, Sebastiao M. B.
    Stefano, Jose Tadeu
    Oliveira, Claudia P.
    [J]. ANNALS OF HEPATOLOGY, 2019, 18 (03) : 416 - 421
  • [6] Pathogenesis of nonalcoholic steatohepatitis (NASH)
    Pirlich, M
    Lochs, H
    Schmidt, HHJ
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2001, 39 (05): : 441 - 442
  • [7] High Risk of Mortality and Disease Progression Associated with Diabetes Mellitus (DM) and Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) in Medicare Patients
    Loomba, Rohit
    Fraysse, Jeremy
    Li, Suying
    Ozbay, A. Burak
    [J]. DIABETES, 2019, 68
  • [8] Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH)
    Ota, Tsuguhito
    [J]. CAROTENOIDS: BIOSYNTHETIC AND BIOFUNCTIONAL APPROACHES, 2021, 1261 : 223 - 229
  • [9] Prevalence and clinical features associated with autoantibodies in nonalcoholic steatohepatitis (NASH).
    Kanji, K
    Jakate, S
    Keshavarzian, A
    Jensen, DM
    Cotler, SJ
    [J]. HEPATOLOGY, 2003, 38 (04) : 506A - 506A
  • [10] Nonalcoholic Steatohepatitis (NASH)-Associated Hepatocellular Carcinoma without Cirrhosis
    Kim, Alexander
    Miao, Chuan
    Pineda, John
    Haider, Fyeza
    Johal, Amitpal
    Smith, Robert
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S158 - S158
12345